QT Imaging Posts 133% Revenue Surge on Strong Scanner Shipments
Event summary
- QT Imaging reported $6.5 million in Q1 2026 revenue, up 133% YoY, driven by 13 Breast Acoustic CT scanner shipments.
- Secured a Category III CPT code (X579T) for its technology, effective January 2027.
- Received FDA 510(k) clearance for enhanced posterior breast tissue visualization.
- Extended senior secured term loan maturity to March 2029, increasing interest rate to 12%.
- Signed multiyear commercial agreement in the UAE with minimum order quantities totaling 43 scanners.
The big picture
QT Imaging's strong Q1 2026 performance highlights its progress in commercializing its radiation-free breast imaging technology. The company's strategic focus on securing regulatory approvals and expanding internationally positions it to capitalize on the growing demand for advanced breast health management solutions. However, its ability to maintain financial discipline amid rising expenses and debt obligations will be critical for long-term success.
What we're watching
- Commercial Execution
- Whether QT Imaging can sustain its shipment momentum to meet its $39 million revenue guidance for 2026.
- Regulatory Momentum
- The pace at which QT Imaging secures additional regulatory clearances to expand its international footprint.
- Financial Health
- How the company manages its increased debt burden and operating expenses while maintaining growth.